Antisecretory drugs and gastric cancer.
作者信息
Langman M J
出版信息
Br Med J (Clin Res Ed). 1985 Jun 22;290(6485):1850-2. doi: 10.1136/bmj.290.6485.1850.
Abstract
摘要
相似文献
1
Antisecretory drugs and gastric cancer.抗分泌药物与胃癌
Br Med J (Clin Res Ed). 1985 Jun 22;290(6485):1850-2. doi: 10.1136/bmj.290.6485.1850.
2
Inhibition of acid and gastric carcinoids.酸与胃类癌的抑制作用。
Gut. 1985 Dec;26(12):1279-83. doi: 10.1136/gut.26.12.1279.
3
Histamine-2 receptor antagonists and gastric cancer.组胺-2受体拮抗剂与胃癌
Epidemiology. 1996 Jul;7(4):434-6. doi: 10.1097/00001648-199607000-00016.
4
Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.组胺H2受体拮抗剂在十二指肠溃疡短期和长期治疗中的应用
Clin Gastroenterol. 1984 May;13(2):501-41.
5
[Cimetidine and stomach carcinoma].[西咪替丁与胃癌]
Ned Tijdschr Geneeskd. 1981 Nov 21;125(47):1929-31.
6
Confounding by indication?指征性混杂？
Epidemiology. 1997 Jan;8(1):110-1.
7
Confounding by indication.指征性混杂
Epidemiology. 1996 Jul;7(4):335-6.
8
Histamine-2-receptor antagonists and gastric cancer: update and note on latency and covariates.组胺-2受体拮抗剂与胃癌：最新进展及关于潜伏期和协变量的说明
Nutrition. 1992 May-Jun;8(3):177-81.
9
H2-receptor antagonists and gastric cancer.H2受体拮抗剂与胃癌
Med Toxicol. 1986 May-Jun;1(3):163-8. doi: 10.1007/BF03259835.
10
[Adverse effects of H2 blockaders].[H2受体阻滞剂的不良反应]
Acta Gastroenterol Latinoam. 1980;10(4):317-23.
引用本文的文献
1
PPIs and gastric cancer: any causal relationship?PPIs 与胃癌：存在因果关系吗？
Acta Biomed. 2023 Jun 14;94(3):e2023096. doi: 10.23750/abm.v94i3.14105.
2
Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.抑酸药物与胃癌：观察性研究的荟萃分析。
World J Gastroenterol. 2013 Apr 28;19(16):2560-8. doi: 10.3748/wjg.v19.i16.2560.
3
Clinical aspects of ECL-cell abnormalities.肠嗜铬细胞异常的临床方面。
Yale J Biol Med. 1998 May-Aug;71(3-4):303-10.
4
Safety of acid-suppressing drugs.抑酸药物的安全性。
Dig Dis Sci. 1995 Feb;40(2 Suppl):63S-80S. doi: 10.1007/BF02214872.
5
Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.奥美拉唑。对其药效学和药代动力学特性以及在消化性溃疡疾病和佐林格-埃利森综合征中的治疗潜力的初步综述。
Drugs. 1986 Jul;32(1):15-47. doi: 10.2165/00003495-198632010-00002.
6
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.奥美拉唑与西咪替丁对幽门前胃溃疡的作用：双盲对比试验。
Gut. 1988 Feb;29(2):249-53. doi: 10.1136/gut.29.2.249.
7
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial.奥美拉唑与雷尼替丁治疗反流性食管炎：双盲对照试验
Br Med J (Clin Res Ed). 1988 Jan 9;296(6615):89-92. doi: 10.1136/bmj.296.6615.89.
8
Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.米索前列醇。对其药效学和药代动力学特性以及治疗消化性溃疡疾病疗效的初步综述。
Drugs. 1987 Jan;33(1):1-30. doi: 10.2165/00003495-198733010-00001.
9
There is more to healing ulcers than suppressing acid.治疗溃疡不仅仅是抑制胃酸。
Gut. 1986 May;27(5):475-80. doi: 10.1136/gut.27.5.475.
10
Gastroesophageal reflux: clinical presentations, diagnosis and management.胃食管反流：临床表现、诊断与管理
CMAJ. 1986 Nov 15;135(10):1101-9.
本文引用的文献
1
Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment.西咪替丁治疗期间胃内亚硝酸盐、亚硝胺及细菌过度生长情况。
Gut. 1982 Dec;23(12):1048-54. doi: 10.1136/gut.23.12.1048.
2
Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.西咪替丁与胃癌：上市后监测研究的初步报告
Br Med J (Clin Res Ed). 1982 Nov 6;285(6351):1311-3. doi: 10.1136/bmj.285.6351.1311.
3
Intragastric N-nitrosation is unlikely to be responsible for gastric carcinoma developing after operations for duodenal ulcer.胃内亚硝化作用不太可能是十二指肠溃疡手术后发生胃癌的原因。
Gut. 1984 Mar;25(3):238-45. doi: 10.1136/gut.25.3.238.
4
Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole.奥美拉唑治疗前、治疗期间及治疗后的胃内细菌活性及亚硝化作用。
Br Med J (Clin Res Ed). 1984 Sep 22;289(6447):717-9. doi: 10.1136/bmj.289.6447.717.
5
Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.西咪替丁安全性的上市后监测：12个月死亡率报告。
Br Med J (Clin Res Ed). 1983 May 28;286(6379):1713-6. doi: 10.1136/bmj.286.6379.1713.
6
The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy.胃嗜银性类癌肿瘤与非胃窦部胃萎缩综合征
Ann Intern Med. 1983 Dec;99(6):761-6. doi: 10.7326/0003-4819-99-6-761.
7
Gastric carcinoid (gastrinoma) associated with achlorhydria (pernicious anemia).与胃酸缺乏（恶性贫血）相关的胃类癌（胃泌素瘤）。
Cancer. 1983 Jun 15;51(12):2332-40. doi: 10.1002/1097-0142(19830615)51:12<2332::aid-cncr2820511228>3.0.co;2-i.
8
Pathologic findings in the stomachs of rats treated with the H2-receptor antagonist tiotidine.用H2受体拮抗剂替奥替丁治疗的大鼠胃部的病理检查结果。
Scand J Gastroenterol Suppl. 1984;101:109-17.
9
Pathology of the forestomach in rats treated for 1 year with a new histamine H2-receptor antagonist, SK&F 93479 trihydrochloride.用新型组胺H2受体拮抗剂盐酸SK&F 93479对大鼠进行1年治疗后前胃的病理学变化
Scand J Gastroenterol Suppl. 1984;101:103-8.
10
Mutagenicity in gastric juice.胃液中的致突变性。
Gut. 1984 Jul;25(7):723-7. doi: 10.1136/gut.25.7.723.
Zotero 插件